A critical discovery in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial malignant suppressor protein is frequently disabled in several types of tumors, resulting https://bookmarkinglife.com/story7659326/vhh-fragments-revive-tumor-suppressor-p53-a-promising-hope-for-malignant-therapy